# Medicare Stars - Measure Quick Reference

## Part C (Medicare Advantage) Measures

### HD1: Staying Healthy - Screenings, Tests and Vaccines

| Code | Measure Name | Data Source | Period | Higher Better? |
|------|-------------|-------------|---------|----------------|
| **C01** | Breast Cancer Screening | Claims | 2024 Full Year | âœ“ |
| **C02** | Colorectal Cancer Screening | Claims | 2024 Full Year | âœ“ |
| **C03** | Annual Flu Vaccine | Survey | Mar-May 2025 | âœ“ |
| **C04** | Improving or Maintaining Physical Health | HOS | Jul-Nov 2024 | âœ“ |
| **C05** | Improving or Maintaining Mental Health | HOS | Jul-Nov 2024 | âœ“ |
| **C06** | Monitoring Physical Activity | HOS | Jul-Nov 2024 | âœ“ |

**5-Star Thresholds**: C01: â‰¥84%, C02: â‰¥78%, C03: â‰¥73, C04: â‰¥75%, C05: â‰¥88%, C06: â‰¥59%

---

### HD2: Managing Chronic (Long Term) Conditions

| Code | Measure Name | Data Source | Period | Higher Better? |
|------|-------------|-------------|---------|----------------|
| **C07** | SNP Care Management | Claims | 2024 Full Year | âœ“ |
| **C08** | Care for Older Adults â€“ Medication Review | Claims | 2024 Full Year | âœ“ |
| **C09** | Care for Older Adults â€“ Pain Assessment | Claims | 2024 Full Year | âœ“ |
| **C10** | Osteoporosis Management (Women w/ Fracture) | Claims | 2024 Full Year | âœ“ |
| **C11** | Diabetes Care â€“ Eye Exam | Claims | 2024 Full Year | âœ“ |
| **C12** | Diabetes Care â€“ Blood Sugar Controlled | Claims | 2024 Full Year | âœ“ |
| **C13** | Kidney Health Evaluation for Diabetes | Claims | 2024 Full Year | âœ“ |
| **C14** | Controlling High Blood Pressure | Claims | 2024 Full Year | âœ“ |
| **C15** | Reducing the Risk of Falling | HOS | Jul-Nov 2024 | âœ“ |
| **C16** | Improving Bladder Control | HOS | Jul-Nov 2024 | âœ“ |
| **C17** | Medication Reconciliation Post-Discharge | Claims | 2024 Full Year | âœ“ |
| **C18** | Plan All-Cause Readmissions | Claims | 2024 Full Year | âœ— LOWER BETTER |
| **C19** | Statin Therapy for Cardiovascular Disease | Claims | 2024 Full Year | âœ“ |
| **C20** | Transitions of Care | Claims | 2024 Full Year | âœ“ |
| **C21** | Follow-up after ED Visit (High-Risk Chronic) | Claims | 2024 Full Year | âœ“ |

**Key Insights**:
- **C18 is INVERSE**: Lower readmission rate = better performance
- **C07 SNP-only**: Only Special Needs Plans report this measure
- **C08-C09**: High performers often achieve 95%+ (excellent documentation)
- **C11-C14**: Diabetes/hypertension measures - focus area for many plans

**5-Star Thresholds**: C08: â‰¥98%, C09: â‰¥99%, C11: â‰¥86%, C12: â‰¥91%, C14: â‰¥86%, C18: â‰¤7%, C19: â‰¥91%

---

### HD3: Member Experience with Health Plan

| Code | Measure Name | Data Source | Period | Higher Better? |
|------|-------------|-------------|---------|----------------|
| **C22** | Getting Needed Care | CAHPS | Mar-May 2025 | âœ“ |
| **C23** | Getting Appointments and Care Quickly | CAHPS | Mar-May 2025 | âœ“ |
| **C24** | Customer Service | CAHPS | Mar-May 2025 | âœ“ |
| **C25** | Rating of Health Care Quality | CAHPS | Mar-May 2025 | âœ“ |
| **C26** | Rating of Health Plan | CAHPS | Mar-May 2025 | âœ“ |
| **C27** | Care Coordination | CAHPS | Mar-May 2025 | âœ“ |

**Key Insights**:
- **CAHPS measures**: Consumer Assessment of Healthcare Providers and Systems
- **Survey-based**: Member perceptions, not administrative data
- **Harder to control**: Subjective ratings influenced by many factors
- **Typically cluster**: Most plans score 80-90 range

**5-Star Thresholds**: C22: â‰¥84, C23: â‰¥86, C24: â‰¥92, C25: â‰¥88, C26: â‰¥89, C27: â‰¥89

---

### HD4: Member Complaints and Changes in Health Plan's Performance

| Code | Measure Name | Data Source | Period | Higher Better? |
|------|-------------|-------------|---------|----------------|
| **C28** | Complaints about the Health Plan | CMS Admin | 2024 Full Year | âœ— LOWER BETTER |
| **C29** | Members Choosing to Leave the Plan | CMS Admin | 2024 Full Year | âœ— LOWER BETTER |
| **C30** | Health Plan Quality Improvement | Calculated | Not Applicable | âœ“ |

**Key Insights**:
- **C28, C29 are INVERSE**: Lower = better (fewer complaints, less disenrollment)
- **C30 is composite**: Measures improvement across multiple measures
- **High weight**: These measures significantly impact overall rating

**5-Star Thresholds**: C28: â‰¤0.11, C29: â‰¤8%, C30: â‰¥0.391253

---

### HD5: Health Plan Customer Service

| Code | Measure Name | Data Source | Period | Higher Better? |
|------|-------------|-------------|---------|----------------|
| **C31** | Plan Makes Timely Decisions about Appeals | CMS Admin | 2024 Full Year | âœ“ |
| **C32** | Reviewing Appeals Decisions | CMS Admin | 2024 Full Year | âœ“ |
| **C33** | Call Center Language & TTY Availability | Survey | Feb-May 2025 | âœ“ |

**Key Insights**:
- **C31, C32**: Operational excellence measures
- **C33**: Accessibility for non-English speakers and hearing impaired
- **Often 95%+**: Most plans perform well on these

**5-Star Thresholds**: C31: 100%, C32: 100%, C33: 100%

---

## Part D (Prescription Drug) Measures

### DD1: Drug Plan Customer Service

| Code | Measure Name | Data Source | Period | Org Type | Higher Better? |
|------|-------------|-------------|---------|----------|----------------|
| **D01** | Call Center Language & TTY Availability | Survey | Feb-May 2025 | MA-PD & PDP | âœ“ |

**5-Star Thresholds**: MA-PD: 100%, PDP: 100%

---

### DD2: Member Complaints and Changes in Drug Plan's Performance

| Code | Measure Name | Data Source | Period | Org Type | Higher Better? |
|------|-------------|-------------|---------|----------|----------------|
| **D02** | Complaints about the Drug Plan | CMS Admin | 2024 Full Year | MA-PD & PDP | âœ— LOWER BETTER |
| **D03** | Members Choosing to Leave the Plan | CMS Admin | 2024 Full Year | MA-PD & PDP | âœ— LOWER BETTER |
| **D04** | Drug Plan Quality Improvement | Calculated | Not Applicable | MA-PD & PDP | âœ“ |

**Key Insights**:
- **D02, D03 are INVERSE**: Lower = better
- **Different thresholds for MA-PD vs PDP**: Standalone drug plans held to different standards

**5-Star Thresholds**: 
- MA-PD: D02: â‰¤0.11, D03: â‰¤8%, D04: â‰¥0.579545
- PDP: D02: â‰¤0.03, D03: â‰¤3%, D04: â‰¥0.672727

---

### DD3: Member Experience with the Drug Plan

| Code | Measure Name | Data Source | Period | Org Type | Higher Better? |
|------|-------------|-------------|---------|----------|----------------|
| **D05** | Rating of Drug Plan | CAHPS | Mar-May 2025 | MA-PD & PDP | âœ“ |
| **D06** | Getting Needed Prescription Drugs | CAHPS | Mar-May 2025 | MA-PD & PDP | âœ“ |

**Key Insights**:
- **CAHPS measures**: Survey-based member experience
- **Critical differentiators**: Often determine 3-star vs 4-star

**5-Star Thresholds**:
- MA-PD: D05: â‰¥89, D06: â‰¥91
- PDP: D05: â‰¥88, D06: â‰¥91

---

### DD4: Drug Safety and Accuracy of Drug Pricing

| Code | Measure Name | Data Source | Period | Org Type | Higher Better? |
|------|-------------|-------------|---------|----------|----------------|
| **D07** | MPF Price Accuracy | Pharmacy | Jan-Sep 2024 | MA-PD & PDP | âœ“ |
| **D08** | Medication Adherence for Diabetes | Pharmacy | 2024 Full Year | MA-PD & PDP | âœ“ |
| **D09** | Medication Adherence for Hypertension | Pharmacy | 2024 Full Year | MA-PD & PDP | âœ“ |
| **D10** | Medication Adherence for Cholesterol | Pharmacy | 2024 Full Year | MA-PD & PDP | âœ“ |
| **D11** | MTM Program Completion Rate for CMR | Program Data | 2024 Full Year | MA-PD & PDP | âœ“ |
| **D12** | Statin Use in Persons with Diabetes | Pharmacy | 2024 Full Year | MA-PD & PDP | âœ“ |

**Key Insights**:
- **D08-D10 are PDC measures**: Proportion of Days Covered (adherence metric)
- **High weight**: Adherence measures significantly impact Part D rating
- **Common targets**: Most plans focus heavily on these
- **Typical range**: 85-92% for top performers

**5-Star Thresholds**:
- MA-PD: D07: â‰¥99, D08: â‰¥92%, D09: â‰¥93%, D10: â‰¥93%, D11: â‰¥96%, D12: â‰¥93%
- PDP: D07: â‰¥99, D08: â‰¥92%, D09: â‰¥93%, D10: â‰¥92%, D11: â‰¥83%, D12: â‰¥86%

---

## Measure Categories

### By Data Source

**Claims Data** (19 measures):
- C01-C02, C07-C14, C17-C20
- Most reliable, large sample sizes
- Direct from administrative systems

**CAHPS Survey** (8 measures):
- C22-C27, D05-D06
- Member perceptions
- Harder to influence directly

**HOS Survey** (5 measures):
- C04-C06, C15-C16
- Health Outcomes Survey
- Functional status and well-being

**Pharmacy Data** (6 measures):
- D07-D12
- Claims-based
- Focus on adherence and utilization

**CMS Administrative** (6 measures):
- C28-C29, C31-C32, D02-D03
- Operational performance
- Complaints, disenrollment, appeals

**Calculated/Composite** (2 measures):
- C30, D04
- Quality Improvement scores
- Based on changes across multiple measures

---

## Inverse Measures (Lower = Better)

âš ï¸ **Important**: These 3 measures are scored INVERSELY:

1. **C18**: Plan All-Cause Readmissions
   - Lower readmission rate = Higher stars
   - 5 stars: â‰¤7%, 1 star: >12%

2. **C28**: Complaints about the Health Plan
   - Fewer complaints = Higher stars
   - 5 stars: â‰¤0.11, 1 star: >1.34

3. **C29**: Members Choosing to Leave the Plan
   - Lower disenrollment = Higher stars
   - 5 stars: â‰¤8%, 1 star: >39%

4. **D02**: Complaints about the Drug Plan
   - Fewer complaints = Higher stars
   - MA-PD 5 stars: â‰¤0.11, PDP 5 stars: â‰¤0.03

5. **D03**: Members Choosing to Leave the Plan (Drug)
   - Lower disenrollment = Higher stars
   - MA-PD 5 stars: â‰¤8%, PDP 5 stars: â‰¤3%

---

## High-Impact Measures

### Highest Weight in Overall Rating

Based on typical CMS weighting:

**Part C - Top Priority**:
1. **C18**: All-Cause Readmissions (Weight: 3x)
2. **C14**: Controlling Blood Pressure (Weight: 3x)
3. **C11-C13**: Diabetes measures (Weight: 1x each, but 3 measures)
4. **C28**: Complaints (Weight: 2x)

**Part D - Top Priority**:
1. **D08-D10**: Medication adherence trio (Weight: 1x each)
2. **D05-D06**: Member experience (Weight: 2x each)
3. **D02-D03**: Complaints and disenrollment (Weight: 2x each)

---

## Common Performance Patterns

### Typically High Performance (Most Plans 4-5 Stars)

- **C08**: Medication Review (90%+ common)
- **C09**: Pain Assessment (95%+ common)
- **C31-C32**: Appeals timeliness (95%+ common)
- **D07**: Pricing accuracy (95%+ common)

### Typically Low Performance (Many Plans 2-3 Stars)

- **C10**: Osteoporosis management (sample size issues)
- **C15-C16**: Falls risk, bladder control (behavioral change hard)
- **C18**: Readmissions (systemic issue)
- **C22-C23**: Getting care quickly (access challenges)

### Highest Variance (Wide Range of Performance)

- **C03**: Flu vaccine (depends on outreach effectiveness)
- **C12**: Diabetes blood sugar control (patient compliance)
- **D08-D10**: Medication adherence (pharmacy partnerships)
- **CAHPS measures**: All show wide variance

---

## Quick Improvement Strategies

### Easy Wins (Documentation-Based)

- **C08-C09**: Improve provider documentation
- **C17**: Better discharge protocols
- **C31-C32**: Streamline appeals processes

### Medium Difficulty (Program-Based)

- **C01-C02**: Outreach campaigns for screenings
- **C07**: Enhanced SNP care management
- **D08-D10**: Pharmacy adherence programs
- **D11**: MTM completion initiatives

### Hard (Long-Term Quality Improvement)

- **C18**: Readmissions reduction (care transitions)
- **C14**: Blood pressure control (clinical interventions)
- **C22-C27**: Member experience (cultural change)
- **C28-C29**: Reduce complaints/disenrollment (systemic)

---

## Data Status Values

### Valid Numeric Data
- Actual percentage or rate
- Star rating assigned (1-5)

### Special Statuses (No Star Rating)
- **"Plan not required to report measure"**: Type exemption (expected)
- **"Plan too small to be measured"**: <11 enrollees or insufficient sample
- **"Not enough data available"**: Sample size below threshold
- **"Plan too new to be measured"**: First 3 years (hold harmless)
- **"No data available"**: Missing submission (investigate)
- **"Medicare shows only a Star Rating"**: Value suppressed for privacy

---

## Measurement Periods

| Period | Measures | Note |
|--------|----------|------|
| **Jan-Dec 2024** | Most claims measures | Full calendar year |
| **Jan-Sep 2024** | D07 (pricing) | 9 months |
| **Feb-May 2025** | C33, D01 (call center) | Survey period |
| **Mar-May 2025** | CAHPS (C22-C27, D05-D06) | Survey period |
| **Jul-Nov 2024** | HOS (C04-C06, C15-C16) | Survey period |
| **Not Applicable** | C30, D04 (QI) | Calculated from changes |

**Key Insight**: 2026 Star Ratings published Oct 2025 based primarily on 2024 data (1-year lag)

---

## Organization Type Differences

### MA-Only (H-contracts, no drug)
- Reports: C01-C33 only
- Part D summary: "Not Applicable"
- Overall rating: Based on Part C only

### MA-PD (H-contracts with drug)
- Reports: C01-C33 + D01-D12
- Uses MA-PD thresholds for Part D
- Overall rating: Combines Part C and Part D

### PDP (S-contracts, drug only)
- Reports: D01-D12 only
- Uses PDP thresholds (stricter than MA-PD)
- Part C summary: "Not Applicable"
- Overall rating: Based on Part D only

### SNP (Special Needs Plans)
- Can be MA-only or MA-PD
- Must report C07 (SNP Care Management)
- May have different performance patterns

---

## Color Coding for Quick Scanning

In reports, consider using:

- ðŸŸ¢ **Green**: 4-5 stars (above average)
- ðŸŸ¡ **Yellow**: 3 stars (average)
- ðŸŸ  **Orange**: 2 stars (below average)
- ðŸ”´ **Red**: 1 star (needs urgent attention)
- âšª **Gray**: Not enough data / Not required

For inverse measures (C18, C28-C29, D02-D03), flip the logic!

---

## Usage Tips

1. **Start with Summary**: Check overall rating first
2. **Identify gaps**: Focus on 1-2 star measures
3. **Calculate gaps**: How far to next threshold?
4. **Prioritize**: High weight + small gap = quick wins
5. **Benchmark**: Compare to industry percentiles
6. **Track trends**: Multi-year view shows momentum

---

*Quick reference for all 45 Medicare Star Rating measures*  
*Last Updated: October 17, 2025*  
*Data Year: 2026 Star Ratings*

